Incorporated by reference in its entirety herein is a computer-readable nucleotide/amino acid sequence listing submitted concurrently herewith and identified as follows: One 172,147 byte ASCII (text) file named “SeqList” created on Apr. 17, 2020.
The disclosure relates to replicating geminiviral expression systems modified to reduce cell death while enhancing the production of biopharmaceutical proteins.
Plant-based expression systems offer many potential advantages over traditional systems, including safety, speed, versatility, scalability, and cost (Chen and Davis, 2016; Gleba et al., 2014; Nandi et al., 2016; Tusé et al., 2014). The demonstration that plant-made pharmaceuticals can be glyco-engineered to have authentic human N-glycans, with greater homogeneity and subsequently greater efficacy than their mammalian-produced counterparts further underscores the potential of plant-based systems for the production of therapeutic proteins (Zeitlin et al. 2011, Hiatt et al. 2014, Strasser et al. 2014). Transient expression systems have become the most commonly used systems to produce recombinant proteins in plants (Gleba et al., 2014). However, high accumulation of foreign proteins, especially when ER-targeted, often puts significant stress on the plant cells. In some cases, this may lead to prohibitive levels of tissue necrosis that reduce yields (Hamorsky et al., 2015).
A plant-based transient expression system has been developed which uses the replication machinery from the geminivirus bean yellow dwarf virus (BeYDV) to substantially increase transgene copy number in the plant nucleus, with a subsequent increase in transcription of the target gene (Huang et al., 2009, 2010). This system has been used to produce high levels of vaccine antigens and pharmaceutical proteins in Nicotiana benthamiana leaves (Phoolcharoen et al. 2011; Lai et al. 2012; Moon et al. 2014; Kim et al. 2015; Diamos et al. 2016; Diamos and Mason 2018). High levels of tissue necrosis have been noted when expressing certain proteins using BeYDV vectors, including Ebolavirus glycoprotein, hepatitis B core antigen, GII norovirus particles, monoclonal antibodies and other ER-targeted proteins (Phoolcharoen et al. 2011; Mathew et al. 2014, and unpublished data). Thus, while the BeYDV system can increase the amount of biopharmaceutical protein produced, overall productivity may be reduced or not increased compared to other plant-based expression system due to high level of cell death in the plant. Accordingly, the problem of reducing plant tissue necrosis during the production of biopharmaceutical proteins remains unaddressed.
The disclosure relates to a T-DNA region. In certain embodiments, the T-DNA region comprises a replicon cassette and an expression cassette, wherein the replicon cassette comprises a rep gene or repA gene from a mastrevirus with a mutation in its 5′ untranslated region (UTR). In some aspects, the mutation is at the translation initiation site of the rep gene or repA gene, namely at position −3. In certain embodiments, the nucleic acid at position −3 is not A or G, e.g., the nucleic acid at position −3 is T or C. For example, the sequence of the translation initiation site is CACATG. Thus, the disclosure also relates to a T-DNA binary vector having the described T-DNA region.
The disclosure also relates to replicon vector designs. In one aspect, the replicon vector is a T-DNA binary vector with a T-DNA region comprising a sequence encoding RepA and a sequence encoding the promoter of ubiquitin-3 from potato with ubiquitin fusion. In another aspects, the replicon vector is a T-DNA binary vector with a T-DNA region comprising a sequence encoding Rep and a sequence encoding the promoter of ubiquitin-3 from potato with ubiquitin fusion.
The disclosure further relates to a replicating geminiviral expression system. In some embodiments, the replicating geminiviral expression system comprises a first cloning vector with a T-DNA region comprising a sequence encoding Rep and a sequence encoding the promoter of ubiquitin-3 from potato with ubiquitin fusion; a second cloning vector with a T-DNA region comprising a sequence encoding RepA and a sequence encoding the promoter of ubiquitin-3 from potato with ubiquitin fusion; and a third cloning vector with a T-DNA region comprising an expression cassette and no replicon cassette. The expression cassette of the third cloning vector comprises a promoter region, a 5′ UTR, a sequence encoding transgene, and a 3′ UTR. In other embodiments, the replicating geminiviral expression system comprises a T-DNA binary vector comprising a first expression cassette, a second expression cassette, and a third expression cassette. The first expression cassette comprises a sequence encoding Rep and a sequence encoding the promoter of ubiquitin-3 from potato with ubiquitin fusion. The second expression cassette comprises a sequence encoding RepA and a sequence encoding the promoter of ubiquitin-3 from potato with ubiquitin fusion. The third expression cassette comprises a promoter region, a 5′ UTR, a sequence encoding transgene, and a 3′ UTR.
The disclosure is additionally directed to methods of expressing a recombinant protein in plant cell. The methods comprising transforming agrobacteria with the above described T-DNA binary vectors and administering the transformed agrobacteria to a plant cell.
Detailed aspects and applications of the disclosure are described below in the following drawings and detailed description of the technology. Unless specifically noted, it is intended that the words and phrases in the specification and the claims be given their plain, ordinary, and accustomed meaning to those of ordinary skill in the applicable arts.
In the following description, and for the purposes of explanation, numerous specific details are set forth in order to provide a thorough understanding of the various aspects of the disclosure. It will be understood, however, by those skilled in the relevant arts, that embodiments of the technology disclosed herein may be practiced without these specific details. It should be noted that there are many different and alternative configurations, devices and technologies to which the disclosed technologies may be applied. The full scope of the technology disclosed herein is not limited to the examples that are described below.
The singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “a step” includes reference to one or more of such steps.
As used herein, the terms “bean yellow dwarf virus vector”, “BeYDV vector,” “BeYDV-based vector,” or a vector of the “BeYDV system” comprises all BeYDV sequences, which are the long intergenic region (LIR), the short intergenic region (SIR), and the rep gene or repA gene. In some aspects, the vectors comprise derivative mutants of BeYDV sequences, for example a rep gene or repA gene mutated at its 5′ UTR, namely the sequence 5′ of its translation initiation site.
As used herein, the term “expression cassette” refers to a distinct component of vector DNA, which contains gene sequences and regulatory sequences to be expressed by the transfected cell. An expression cassette comprises four components (listed from 5′ to 3′): a promoter sequence, 5′ untranslated region (5′ UTR), an open reading frame, and a 3′ untranslated region (3′ UTR). The open reading frame includes the portion of a gene spanning the start codon and the stop codon. Thus, the open reading frame comprises a gene sequence. The regulatory sequences are found in the 5′ UTR and the 3′ UTR. The 5′ UTR refers to the sequence from transcription start site to the start codon. In some aspects, the 3′ UTR comprises the 3′ flanking region (also known as the terminator region) of expression cassette. Thus, in certain embodiments, the 3′ UTR comprises the sequence between the stop codon to the poly(A) site, which is part of the gene sequence, and at least one additional terminator sequence.
As used herein, the term “replicon cassette” refers to an expression cassette comprising at least one gene that assists with replication of an organism's DNA sequence. For example, in certain embodiments, the expression vector disclosed herein comprise a replicon cassette comprising the rep gene or repA from BeYDV.
As used herein, the term “replicon vector” refers to a vector that comprises the cis-acting genetic elements necessary to produce replicons. Thus, a replicon vector comprises as its expression cassette a replicon cassette. For example, in certain embodiments, a replicon vector described herein comprises two flanking LIR regions from bean yellow dwarf virus to designate the borders of the replicon. This segment of DNA is amplified via rolling circle replication and other mechanisms by viral and host genes (rep/repA for bean yellow dwarf virus), creating large numbers of DNA copies which serve as transcription templates for the gene of interest in the plant nucleus.
As used herein, the term “terminator” refers to a DNA sequence that contains polyadenylation signals and causes the dissociation of RNA polymerase from DNA and hence terminates transcription of DNA into mRNA. Accordingly, while the term encompasses terminator sequences of known genes, the term also encompasses other sequences that perform the same function, for example, sequences around the short intergenic region of bean yellow dwarf virus.
As used herein, the term “transgene” refers to a gene from one organism that is introduced into another organism.
The disclosure is directed to that modulating the expression of replication genes in a replicating geminiviral expression system based on bean yellow dwarf virus (BeYDV) improves the suitability of such a system to express transgenes in plants, such as for plant production of biopharmaceutical proteins. While extensive work has been done to optimize the gene expression cassette and other aspects of the BeYDV system (Diamos et al., 2016; Diamos and Mason, 2018), vector replication has not been thoroughly investigated.
Geminiviruses are a family of small (˜2.5 kb) single-stranded DNA viruses which replicate in the nucleus of host cells, associating with histones to form viral chromosomes (Pilartz and Jeske, 2003). BeYDV and other mastreviruses produce only four proteins: a coat protein and movement protein, which are produced by the virion sense DNA strand, and two replication proteins, Rep and RepA, produced on the complementary sense DNA strand (C1/C2 genes). Rep and RepA are produced from a single intron-containing transcript: RepA is the predominant protein product from the unspliced transcript, while a relatively uncommon excision of an intron alters the reading frame to produce Rep. Production of all viral proteins is driven by a single bidirectional promoter in the long intergenic region (LIR) which also contains the viral origin of replication. Both divergent transcripts converge at a short intergenic region (SIR), which has bidirectional transcription terminator signals and is suspected to be the origin of complementary strand synthesis (Liu et al., 1998).
Because geminiviruses produce few gene products, they are heavily reliant on host enzymes. The mastrevirus Rep protein, which is produced early in infection, is a multifunctional protein responsible for initiating rolling circle replication by nicking a conserved stem-loop sequence in the LIR. The majority of replication then occurs using cellular machinery to extend the free 3′ end of the nicked viral replicon, though it is likely that Rep recruits many of the involved cellular factors (Gutierrez, 1999). Rep also plays a role in ligating newly synthesized DNA to create circular viral genomes and possesses helicase activity (Choudhury et al., 2006). In the bipartite begomoviruses, Rep has been shown to form homo-oligomers, or possibly hetero-oligomers with RepA or other proteins, which may play a role in replication (Horvath et al., 1998; Krenz et al., 2011).
A primary function of RepA is thought to be the creation of a cellular environment suitable for replication. Some evidence suggests this occurs by binding retinoblastoma-related proteins, which are involved in cell cycle regulation. With RepA bound, previously sequestered transcription factors are able to initiate S-phase gene expression, creating the cellular machinery necessary for viral replication (Gutierrez et al., 2004). An LxCxE motif has been shown to contribute to retinoblastoma-related protein binding (Ruschhaupt et al., 2013). However, other functions of RepA, many of which are still unidentified, have also been shown to enhance viral replication. A set of proteins known as GRAB proteins, which are involved in leaf development and senescence, have also been found to interact with RepA (Lozano-Duran et al., 2011).
Viral proteins are often potent inducers of the plant hypersensitive response, an immune defense mechanism that triggers the release of reactive oxygen species, autophagy, host translation shutoff, and programmed cell death in response to pathogen infection (Dodds and Rathj en, 2010; Zhou et al., 2014; Zorzatto et al., 2015). In the begomoviruses, the bean dwarf mosaic virus nuclear shuttle protein (NSP) was shown to activate the hypersensitive response in bean plants (Garrido-Ramirez et al., 2000), and this activity was mapped to the N-terminus of the NSP (Zhou et al., 2007). As a countermeasure, the TrAP protein from tomato leaf curl New Delhi virus prevents the activation of the hypersensitive response generated by its NSP (Hussain et al., 2007). Additionally, the NSP is known to interact with a host immune NB-LRR receptor-like kinase to enhance virus pathogenicity and is involved in preventing translation shutoff in response to virus infection (Sakamoto et al., 2012; Zhou et al., 2014). The Rep protein from African cassava mosaic virus also elicited the hypersensitive response in Nicotiana benthamiana (van Wezel et al., 2002), and it was further reported that altering a single amino acid reversed hypersensitive response induction without affecting protein function (Jin et al., 2008). While many studies have focused on the begomoviruses, the role of the hypersensitive response during mastrevirus infection has not been investigated.
As shown in the Examples, by reducing expression of Rep and RepA, BeYDV-based expression vectors elicit lower levels of cell death. The reduced level of cell death does not come as the cost of transgene expression. In fact, the reduced levels of cell death results in a corresponding increase in the production of vaccine antigens and monoclonal antibodies (see, for example,
In some embodiments, the disclosure is directed to a T-DNA region design, wherein the T-DNA region comprises a replicon cassette and an expression cassette, wherein the replicon cassette comprises a rep gene or repA gene from a mastrevirus that has a mutation in the initiation site at position −3, and the nucleic acid at position −3 is not A or G. For example, the nucleic acid at position −3 is T or C. In certain embodiments, the initiation site sequence of the mutated rep gene or repA gene is CACATG. In other embodiments, the initiation site sequence of the mutated rep gene or repA gene is TACATG. In some embodiments, the rep gene or the repA gene is from bean yellow dwarf virus. In some aspects, the nucleic acid sequence of the repA gene has at least 80% similarity, at least 85% similarity, at least 90% similarity, at least 95% similarity, at least 97% similarity, at least 98% similarity, or at least 99% similarity with the sequence spanning position 1308 to 2398 of GeneBank Y11023.2. In some aspects, the nucleic acid sequence of the rep gene has at least 80% similarity, at least 85% similarity, at least 90% similarity, at least 95% similarity, at least 97% similarity, at least 98% similarity, or at least 99% similarity with the sequence spanning position 1308 to 1519 of GeneBank Y11023.2.
To further enhance expression of expression cassette (which comprises a promoter region, a 5′ untranslated region (UTR), a sequence encoding transgene; and a 3′ UTR), the 5′ UTR and/or the 3′ UTR of the expression cassette may be selected from 5′ UTRs and 3′ UTRs that have been identified to result in enhanced recombinant protein expression in plants (see PCT/US2019/020621, the contents of which are incorporated by reference herein). The 3′ UTR regions that provide enhanced production of the recombinant protein include the extensin 3′ UTR (also referenced herein as the extensin terminator), N. benthamiana actin 3′ UTR (NbACT3), potato proteinase inhibitor II 3′ UTR (Pin2), bean dwarf mosaic virus DNA B nuclear shuttle protein 3′ UTR (BDB), N. benthamiana 18.8 kDa class II heat shock protein 3′ UTR (NbHSP), pea rubisco small subunit 3′ UTR (RbcS), A. thaliana heat shock protein 3′ UTR (AtHSP), cauliflower mosaic virus 35S 3′ UTR (35S), and Agrobacterium nopaline synthase 3′ UTR (NOS). The sequences of these 3′UTR are well-known in the art.
In some aspects, the nucleic acid sequence of the extensin terminator is selected from the terminator sequences of the extensin gene in Nicotiana tabacum, Nicotiana tomentosiformis, Nicotiana plumbaginifolia, Nicotinana attenuata, Nicotinana sylvestris, Nicotiana benthamiana, Solanum tuberosum, Solanum lycopersicum, Solanum pennellii, Capsicum annuum, and Arabidopsis thaliana, the sequences of which are determinable from GenBank or the Sol Genomics Network. The nucleic acid sequence of the extension terminator comprises a polypurine sequence, an atypical near upstream element (NUE), an alternative polyA site, a far upstream element (FUE)-like region, a major NUE, and a major polyA region, and in certain embodiments, the nucleic acid sequence has at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, or 79% identity to the sequence of the tobacco (N. tabacum) extension terminator. In some embodiments, the nucleic acid sequence of the extension terminator is that of the tobacco extensin gene. In certain embodiments, the portion of the extensin 3′ UTR in the disclosed vector lacks the intron. In a particular embodiment, the 3′ UTR region of the vector comprises an intronless tobacco extensin terminator (EU). Thus in some aspects, the nucleic acid sequence of EU spans nt 2764-3126 of the complete N. tabcacum gene for extensin (GenBank D13951.1). In certain other embodiments, the disclosed vector comprises intron-containing extensin terminator. Thus in some aspects, the 3′ UTR region of the vector comprises an intron-containing tobacco extensin terminator (IEU). In such embodiments, the nucleic acid sequence of IEU spans nt 2396-3126 of the complete N. tabcacum gene for extensin (GenBank D13951.1).
In some aspects, the nucleic acid sequence of NbACT3 comprises nt 1460-1853 of actin gene (Gene ID Niben101Scf00096g04015.1). In some aspects, the nucleic acid sequence of NbACT3 comprises nt 33-1023 of the sequence set forth in SEQ ID NO. 23. In some aspects, the N. benthamiana actin 3′ UTR is not the entirety of the 3′ UTR, but only the downstream 617-nt region of NbACT3 (NbACT617). In such embodiments, the nucleic acid sequence of NbACT617 comprises nt 606-1023 of the sequence set forth in SEQ ID NO. 23. In other aspects, the N. benthamiana actin 3′ UTR is not the entirety of the 3′ UTR, but only the downstream 567-nt region of NbACT3 (NbACT567).
In some embodiments, the nucleic acid sequence of Pin2 spans nt 1507-1914 of the potato gene for proteinase inhibitor II (GenBank: X04118.1). In some aspects, the sequence of pinII is obtained from pHB114 (Richter et al., 2000) by SacI-EcoRI digestion.
In some embodiments, the nucleic acid sequence of BDB comprises the 3′ end of the nuclear shuttle protein, the intergenic region, the 3′ end of the movement protein, and additional 200 nt downstream of the movement protein sequence (BDB501), which spans nt 1213-1713 of bean dwarf mosaic virus segment DNA-B (GenBank: M88180.1). In some embodiments, the nucleic acid sequence of BDB comprises only the 282 nucleotides that include the 3′ end of the nuclear shuttle protein, the intergenic region, and the 3′ end of the movement protein (BDB282).
In some embodiments, the nucleic acid sequence of NbHSP comprises the complement to nt 988867-989307 of the sequence of Gene ID Niben101Scf04040. In some aspects, the nucleic acid sequence of NbHSP spans nt 33-424, nt 33-447, nt 33-421, nt 33-453, nt 45-424, nt 45-447, nt 45-421, or nt 45-453 of the sequence set forth in SEQ ID NO. 24. In one embodiment, the nucleic acid sequence spanning nt 45-421 of the sequence set forth in SEQ ID NO. 24 is NbHSP. In embodiments, the nucleic acid sequence of NbHSPb comprises the complement to nt 988942-989307 of the sequence of Gene ID Niben101Scf04040. In some aspects, the nucleic acid sequence spanning nt 45-372 of the sequence set forth in SEQ ID NO. 24 is NbHSPb.
In some embodiments, the nucleic acid sequence of rbcS comprises a sequence that is complementary to the sequence spanning nt 6-648 of transient gene expression vector pUCPMA-M24 (GenBank: KT388099.1). In some aspects, the sequence of rbcS is obtained from pRTL2-GUS (Carrington et al., 1999) by SacI-EcoRI digestion.
In some embodiments, the nucleic acid sequence of AtHSP comprises nt 1-250 of the partial sequence of the A. thaliana heat shock protein 18.3 gene (GenBank KP008108.1). In some aspects, the nucleic acid sequence of AtHSP spans nt 7-257 of SEQ ID NO. 25.
In some embodiments, the nucleic acid sequence of 35S comprises a sequence spanning nt 3511-3722 of plant transformation vector pSITEII-8C1 (GenBank: GU734659.1). In some aspects, the sequence of 35S is set forth in nt 7-218 of SEQ ID NO. 26. In some aspects, the sequence of 35S is the sequence of the amplification of pRTL2-GUS (Carrington et al 1991) using the primers 35STm-1 (SEQ ID NO. 27) and 35STm-2 (SEQ ID NO. 27).
In some embodiments, the nucleic acid sequence of NOS comprises nt 22206-22271 of the T-DNA region of cloning vector pSLJ8313 (GenBank: Y18556.1). In some aspects, the sequence of NOS is that of the fragment obtained from pHB103 (Richter et al., 2000) by SacI-EcoRI digestion. In some aspects, the nucleic acid sequence of NOS is set forth in nt 6-261 of SEQ ID NO. 29.
In some embodiments, the 3′ UTR region comprises at least one member from the group consisting of: EU5, IEU, NbACT3, NbACT617, NbACT567, Pin2, BDB501, BDB282, NbHSP, NbHSPb, RbcS, AtHSP, 35S, and NOS. In certain embodiments, the 3′ UTR region of the vector consists of a terminator selected from the group consisting of: EU, NbACT3, Pin2, BDB501, NbHSP, RbcS, NbACT617, NbACT567, NbHSPb, and AtHSP. In some implementations, the 3′ UTR region of the vector consists of a terminator selected from the group consisting of: EU, NbACT3, Pin2, BDB501, NbHSP, and RbcS.
In some aspects, the 3′ UTR comprises two terminators, which produces a double terminator. The double terminator may be a repeat of same terminator or a combination of different terminators (for example, a fusion of two different terminators). In some embodiments, the double terminator consists of EU with NbACT, P19, NbHSP, SIR, NOS, 35S, tobacco mosaic virus 3′ UTR (TMV), BDB501, tobacco necrosis virus-D 3′ UTR (TNVD), pea enation mosaic virus 3′ UTR (PEMV), or barley yellow dwarf virus 3′ UTR (BYDV). In some aspects, the aforementioned pair of terminators are arranged where EU is arranged upstream of the other terminator, which is denoted as EU+NbACT, EU+P19, EU+NbHSP, EU+SIR, EU+NOS, EU+35S, EU+TMV, EU+BDB501, EU+TNVD, EU+PEMV, or EU+BYDV. In some embodiments, the double terminator consists of 35S with NbACT3, NOS, EU, NbHSP, Pin2, or BDB501. In some aspects, the aforementioned pair of terminators are arranged where 35S is arranged upstream of the other terminator, which is denoted as 35S+NbACT3, 35S+NOS, 35S+EU, 35S+NbHSP, 35S+Pin2, or 35S+BDB501. In some embodiments, the double terminator consists of IEU with SIR, 35S, or LIR. In some aspects, the aforementioned pair of terminators are arranged where IEU is arranged upstream of the other terminator, which are denoted as IEU+SIR, IEU+35S, or IEU+LIR. In some embodiments, the double terminator consists of NbHSP with NbACT3, NOS, or Pin2. In some aspects, the aforementioned pair of terminators are arranged where NbHSP is upstream of the other terminator, which is denoted as NbHSP+NbACt3, NbHSP+NOS, or NbHSP+Pin2. In some embodiments, the double terminator consists of NOS with 35S, where NOS is arranged upstream of 35S (NOS+35S).
As used herein, the term “P19” refers to the P19 suppressor of RNAi silencing. An exemplary vector backbone that comprises P19 is pEAQ-HT (see Sainsbury et al., 2009).
In accordance with certain embodiments, the nucleic acid sequence of TMV spans nt 489-693 of the tobacco mosaic virus isolate TMV-JGL coat protein gene (GenBank: KJ624633.1). In some aspects, the nucleic acid sequence of TMV is set forth in nt 7-211 of SEQ ID NO. 30.
In accordance with certain embodiments, the nucleic acid sequence of TNVD has at least 85% identity, preferably 87% identity, to the sequence spanning nt 3457-3673 of the complete genome of tobacco necrosis virus D genome RNA (GenBank: D00942.1). In other embodiments, the nucleic acid sequence of TNVD has at least 90%, preferably 93%, sequence identity with nt 3460-3673 of tobacco necrosis virus-D genome (GenBank: U62546.1). In some embodiments, the nucleic acid sequence of TNVD comprises the sequence set forth in nt 29-222 of SEQ ID NO. 31.
In accordance with certain embodiments, the nucleic acid sequence of PEMV has at least 95%, preferably 98%, sequence identity with nt 3550-4250 of the pea enation mosaic virus-2 strain UK RNA-dependent RNA-polymerase, hypothetical protein, phloem RNA movement protein, and cell-to-cell RNA movement protein genes (GenBank: AY714213.1). In some aspects, the nucleic acid sequence of PEMV is set forth in nt 1-703 of SEQ ID NO. 13.
In accordance with certain embodiments, the nucleic acid sequence of BYDV has at least 95%, preferably 99%, sequence identity with nt 4807-5677 of barley yellow dwarf virus—PAV genomic RNA (GenBank: X07653.1). In some aspects, the nucleic acid sequence of BYDV is set forth in nt 5-875 of SEQ ID NO. 11.
SEQ ID NOs. 23-36 provides the nucleic acid sequences for incorporating the aforementioned 3′ UTRs into the T-DNA region. The nucleic acid sequence of the template for incorporating NOS is set forth in SEQ ID NO. 29. The nucleic acid sequence of the template for incorporating 35S is set forth in SEQ ID NO. 26. The nucleic acid sequence of the template for incorporating pinII is set forth in SEQ ID NO. 32. The nucleic acid sequence of the template for rbcS is set forth in SEQ ID NO. 33. The nucleic acid sequence of the template for incorporating IEU is set forth in SEQ ID NO. 34. The nucleic acid sequence of the template for incorporating EU is set forth in SEQ ID NO. 35. The nucleic acid sequence of the template for incorporating NbHSP is set forth in SEQ ID NO. 24. The nucleic acid sequence of the template for incorporating NbACT3 is set forth in SEQ ID NO. 23. The nucleic acid sequence of the template for incorporating BDB501 is set form in SEQ ID NO. 36. The nucleic acid sequence of the template for incorporating AtHSP is set forth in SEQ ID NO. 25. The nucleic acid sequence of the template for incorporating barley yellow dwarf virus's (BYDV's) 3′ UTR is set forth in SEQ ID NO. 11. The nucleic acid sequence of the template for incorporating TNVD 3′ UTR is set forth in SEQ ID NO. 31. The nucleic acid sequence of the template for incorporating PEMV 3′ UTR is set forth in SEQ ID NO. 13. The nucleic acid sequence of the template for incorporating tobacco mosaic virus 3′ UTR is set forth in SEQ ID NO. 30.
In some embodiments, the 5′ UTR comprises the 5′ UTR of native Nicotiana benthamiana NbPsaK, the 5′ UTR from barley yellow mosaic virus, or the 5′ UTR from cowpea mosaic virus. In some aspects, the 3′ UTR comprises the 3′ UTR from barley yellow mosaic virus or the 3′ UTR from cowpea mosaic virus. In certain implementations where the 5′ UTR and the 3′ UTR of the expression cassette is from a virus, the 5′ UTR and the 3′ UTR should come from the same virus, for example if the virus is pea enation mosaic virus. In certain embodiments, the 5′ UTR of the expression cassette does not comprise the 5′ UTR from tobacco mosaic virus or the 5′ UTR from pea enation mosaic virus. In certain embodiments, the 3′ UTR does not comprise the 3′ UTR from pea enation mosaic virus.
The expression level of the expression cassette may also be further enhanced by the selection of a strong promoter, for example, 35S promoter from cauliflower mosaic virus.
In a particular embodiment, the T-DNA region design comprises PinII 3′ UTR, P19, 35S promoter, LIR, NbPsaK truncated 5′ UTR, the transgene, intronless extensin 3′ UTR, NbAct3 3′ UTR, Rb7 MAR, SIR, and Rep/RepA with mutated 5′ UTR. In some aspects, the arrangement of the T-DNA region from 5′ to 3′ is: PinII 3′ UTR-P19-35S promoter-LIR-35S promoter-NbPsaK truncated 5′ UTR-transgene-intronless extensin 3′ UTR-NbAct3 3′ UTR-Rb7 MAR-SIR-Rep/RepA with mutated 5′ UTR-LIR.
For the production of recombinant proteins with DNA-based systems, the development of cell death depends on the individual composition of the protein being produced, subcellular localization of the target protein (Howell, 2013), glycosylation of the target protein (Hamorsky et al., 2015), target protein expression level, Agrobacterium strain (Diamos et al., 2016) and concentration (Wroblewski et al. 2005,
In some embodiments, the element of the replicon cassette may be separated from the elements for expression of the transgene, for example a replicating geminiviral expression system comprising three cloning vectors. One of the cloning vectors comprises a T-DNA region that lacks a replicon cassette but comprises an expression cassette that corresponds to above described expression cassette. The other two cloning vectors are replicon vectors where its T-DNA region comprises a sequence encoding Rep or RepA. In some aspects, the T-DNA region of the replicon vectors further comprise a sequence encoding the promoter of ubiquitin-3 from potato with ubiquitin fusion. In such embodiments, the promoter of ubiquitin-3 from potato with ubiquitin fusion drives the expression of Rep and RepA. As the optimal expression level of Rep/RepA varies depending on the gene of interest, the replicon vector may comprise other promoter regions to drive the expression of Rep and RepA. In some aspects, the promoter driving the expression of Rep in one replicon vector is different than the promoter driving the expression of RepA in the other replicon vector. However, in particular embodiments, the ratio of Rep expression to RepA expression is kept at 1:1.
To reduce the amount of agrobacteria needed for infiltration of plant, the three cloning vector replicating geminiviral expression system can readily be simplified into a single vector that supplies all three expression cassettes from a single T-DNA plasmid. In such non-limiting embodiments, the T-DNA binary vector comprising three expression cassettes wherein each of the expression cassette comprises the elements of the above described cloning vectors. For example, one of the expression cassettes comprises a sequence encoding Rep and a sequence encoding the promoter of ubiquitin-3 from potato with ubiquitin fusion, while another one of the expression cassettes comprises a sequence encoding RepA and a sequence encoding the promoter of ubiquitin-3 from potato with ubiquitin fusion. These two expression cassettes correspond to the two replicon vectors. The third expression cassette comprises a promoter region, a 5′ UTR; a sequence encoding a transgene; and a 3′ UTR.
Also disclosed are methods of expressing a recombinant protein in plant cell using the above described T-DNA region design, T-DNA binary vectors, and replicating geminiviral expression system.
In some embodiments, the method comprises administering to a plant cell a composition comprising a first transformed Agrobacterium, a second transformed Agrobacterium, and a third Agrobacterium. The first transformed Agrobacterium is transformed with a first T-DNA binary vector, and the T-DNA region of the first T-DNA binary vector comprises a sequence encoding Rep and a sequence encoding the promoter of ubiquitin-3 from potato with ubiquitin fusion. The second transformed Agrobacterium is transformed with a second T-DNA binary vector, and the T-DNA region of the second T-DNA binary vector comprises a sequence encoding RepA and a sequence encoding the promoter of ubiquitin-3 from potato with ubiquitin fusion. The third transformed Agrobacterium is transformed with a third T-DNA binary vector, and the T-DNA region of the third T-DNA binary vector comprises an expression cassette and no replicon cassette. The expression cassette comprises a promoter region, a 5′ UTR, a sequence encoding the recombinant protein; and a 3′ UTR.
In certain embodiments, the method comprises administering to a plant cell a composition comprising transformed Agrobacterium, wherein the transformed Agrobacterium is transformed with a T-DNA binary vector having a T-DNA region comprising an expression cassette comprising a sequence encoding the recombinant protein and a replicon cassette comprising a mutated rep gene or repA gene. The mutated rep gene or repA gene comprises a mutation in its 5′ UTR. In some aspects, the mutation is in the initiation site sequence, and the initiation site sequence of the mutated Rep/RepA gene is CACATG. In other aspects, the mutation is in the initiation site sequence, and the initiation site sequence of the mutated Rep/RepA gene is TACATG.
In still other non-limiting embodiments, the method comprises administering to a plant cell a composition comprising transformed Agrobacterium, wherein the transformed Agrobacterium is transformed with a T-DNA binary vector having a T-DNA region comprising three expression cassettes. One expression cassette comprises a sequence encoding Rep and a sequence encoding the promoter of ubiquitin-3 from potato with ubiquitin fusion. Another expression cassette comprises a sequence encoding RepA and a sequence encoding the promoter of ubiquitin-3 from potato with ubiquitin fusion. And the third expression cassette comprises a promoter region, a 5′ UTR, a sequence encoding the recombinant protein; and a 3′ UTR.
The disclosure is further illustrated by the following examples that should not be construed as limiting. The contents of all references, patents, and published patent applications cited throughout this application, as well as the Figures, are incorporated herein by reference in their entirety for all purposes.
In the BeYDV expression system (
To create a modular system to study vector replication, a series of Agrobacterium T-DNA expression vectors were constructed that separately expressed either Rep or RepA under the control of five different promoters: the 35S promoter, the nopaline synthase promoter from Agrobacterium (NOS), the vegetative storage protein B promoter from soybean (vspB), or the ubiquitin-3 promoter from potato with (UbiF) or without (Ubi) ubiquitin fusion (
While the 35S promoter is widely known to drive high levels of gene expression, the NOS promoter was reported to be 30-fold weaker than the 35S in transgenic plants (Sanders et al., 1987). All other promoters tested produced substantially lower Rep/RepA than 35S (
To determine the effects of altered Rep and RepA expression on replicon amplification, a replicon vector pBY-2e-sNV encoding a synthetic GI norovirus capsid protein (NVCP) was coinfiltrated with Rep and RepA supplying vectors. For simplicity, further experiments were performed with either UbiF vectors for low expression or 35S vectors for high expression, as no major notable differences were observed among the lower expressing constructs. The vector pBYR2e-sNV, which contains the wildtype Rep/RepA configuration driven by the native LIR promoter, was used as a control. In agreement with previous data on mastrevirus replication (Huang et al., 2009; Ruschhaupt et al., 2013), no replication was detected when RepA alone was supplied, and very low replication was detected when Rep was supplied alone with either a weak or strong promoter (
There is discrepancy in the necessity of RepA for mastreviral rolling circle replication. In cell culture experiments with wheat dwarf virus (Collin et al., 1996) or BeYDV (Hefferon, 2003; Liu et al., 1998), intron-deleted rep has been reported to support high levels of replication. In contrast, maize streak virus only supported very low levels of replication in the absence of RepA (Ruschhaupt et al., 2013). In agreement with the results of Ruschhapt et al, only low levels of replication was observed when expressing rep alone in N. benthamiana leaves, even in the presence of high levels of Rep (
In their native configuration, production of either Rep or RepA is controlled by the excision of an intron and thus the frequency of intron removal controls the relative abundance of each protein. For maize streak virus in infected maize, it has been reported that approximately 80% of transcripts produce RepA, and only 20% produce Rep (Wright et al., 1997). 35S-driven Rep and RepA produced as much or more combined Rep/RepA than the wildtype gene (
Previously, it was shown that coinfiltration of a replicon vector and a Rep/RepA-supplying vector encoding both Rep and RepA together in the native configuration enhances the production of target proteins (Huang et al., 2009; Mor et al., 2003). To further characterize the relationship between replicon amplification and target protein accumulation, the production of NVCP from replicons amplified with variable levels of Rep and RepA was measured by ELISA. The control vector psNV120e contains no BeYDV elements and thus cannot replicate, whereas pBY-2e-sNV contains the intergenic regions from BeYDV necessary for replication. Interestingly, even in the absence of Rep and RepA, pBY-2e-sNV substantially increased NVCP expression by 3.1-fold compared to psNV120e, accumulating NVCP at 0.57 mg/g LFW (
Plants employ the hypersensitive response as a mechanism to combat viral infection. The hypersensitive response is characterized by a burst of reactive oxygen species and the formation of necrotic lesions resulting from programmed cell death. As viral proteins are often contributors to cell death, the individual contribution of BeYDV proteins to plant leaf necrosis was investigated.
Vectors using the strong 35S promoter to express either Rep, RepA, the movement and coat proteins from BeYDV, or GFP were individually agroinfiltrated into N. benthamiana leaves and monitored for leaf tissue health. Both Rep and RepA produced chlorotic leaf tissue by 3-5 DPI which developed signs of leaf browning and eventually progressed to necrotic lesions by 6-10 DPI, whereas the movement protein, coat protein, and GFP did not produce any notable symptoms (
Many DNA viruses have been shown to activate the DNA damage response during replication (Luftig, 2014). Thus, replicon amplification itself might contribute to leaf necrosis. The vector pRep110, which expresses Rep/RepA together in the native configuration and is insufficient to cause significant cell death on its own, was coinfiltrated with either pBY-EMPTY, which contains the cis-elements necessary for replication but with gene coding sequences replaced with a terminator, or pPS1, which contains no replication elements. Leaf spots infiltrated with pBY-EMPTY and pRep110 produced chlorotic leaf tissue after 3-4 DPI, and necrotic leaf tissue after 6-8 DPI, whereas leaf spots infiltrated with pPS1 and Rep/RepA did not produce necrotic tissue up to 10 DPI (
To determine whether a modest reduction in Rep/RepA would also benefit the expression of other transgenes, reduced Rep/RepA vectors were coinfiltrated with either pBY-2e-GFP, encoding GFP, or with pBY-2e-MRtx encoding the heavy and light chains of the monoclonal antibody rituximab. These vectors were compared to replicating vectors containing Rep/RepA in the wildtype configuration driven by the native LIR promoter: pBYR2e-GFP and pBYR2e-MRtx. It was previously shown that pBYR2e-GFP accumulates high levels of GFP (Diamos et al., 2016). While GFP is known to be well tolerated even when produced at very high levels in N. benthamiana leaves, the monoclonal antibody rituximab was found to induce a strong cell death response with BeYDV vectors (Diamos et al., 2016). A small but statistically insignificant decrease was observed in GFP expression when low Rep/RepA were supplied, compared to high Rep/RepA or wildtype, and no cell death was observed with any vector (
Accordingly, using a controlled reduction in Rep/RepA expression, leaf cell death caused by geminiviral replicons is alleviated (
While cell death was reduced and antibody yield was increased by reducing Rep/RepA expression, it required coinfiltration of three separate Agrobacterium vectors. As the native Rep gene also controls the optimum ratio of Rep/RepA by intron splicing, we reasoned that a mutation in the 5′ UTR of Rep/RepA would be a simple modification to simultaneously reduce expression of both genes while maintaining the native mechanism of controlling the relative production of Rep/RepA. The sequence context around the initiation site plays a critical role in translation (Kozak, 1999). Experiments with tobacco cells found that altering the initiation context from CAUAUGC to AAUAUGG (start codon underlined) resulted in a 4-fold increase in gene expression (Ayre, 2002).
To construct a simplified vector with reduced expression of Rep and RepA, single nucleotide mutations were created in the native 5′ UTR of Rep/RepA at the −3 position from the Rep/RepA start codon. These mutations were designed to provide a less favorable sequence context for translation initiation, which has been shown to favor A or G in the −3 position for dicot plants (Sugio et al., 2010). The resulting vector contains an AAUAUG to CAUAUG mutation.
An AACATG to CACATG mutation (where ATG indicates the rep start codon) reduced both Rep/RepA accumulation (
These results also indicate that vector replication can be reduced with a single change from the wildtype Rep/RepA gene. As multiple BeYDV replicons can be placed in tandem on the same T-DNA (Huang et al., 2010), this strategy can be used to produce heteromultimeric proteins from a single vector.
Agrobacterium contributes to the plant cell death response in a complex manner (Hwang et al., 2015), though infiltration with higher Agrobacterium concentrations has often been found to contribute to cell death (Wroblewski et al., 2005). While an Agrobacterium OD600 of ˜0.2 is sufficient to deliver T-DNA to the majority of plant cells, nonreplicating vector systems often use much higher concentrations of Agrobacterium to achieve optimum expression. This may be due to the delivery of multiple DNA copies to each cell, which serve as additional transcription templates. As replicating systems greatly amplify the input T-DNA, additional copies would be unnecessary. In N. benthamiana leaves, Agrobacterium strain EHA105 reduces leaf necrosis relative to other commonly used Agrobacterium strains when used to deliver replicating BeYDV vectors (Diamos et al. 2016). Many nonreplicating vector systems use high Agrobacterium concentrations of around an OD600 of 1.2 (Sainsbury et al., 2009).
To investigate the relationship between Agrobacterium concentration and vector replication, a replicating BeYDV vector expressing GFP was infiltrated at various Agrobacterium concentrations. No significant differences in GFP expression were observed until the OD600 was reduced below 0.2 (
To further evaluate the relationship between Agrobacterium concentration and cell death, replicating BeYDV vectors expressing hepatitis B core antigen tandem-linked heterodimers (Peyret et al., 2015) were infiltrated at decreasing Agrobacterium concentrations. Agrobacterium OD600 concentrations of 1.6 and 0.8 produced visible leaf necrosis, while 0.4 and 0.2 did not (
For the expression of toxic proteins, inventors observed that necrosis developed when using higher Agrobacterium concentrations, but not with lower concentrations (
While no substantial necrosis developed with either BeYDV or pEAQ vectors expressing GFP, leaf chlorosis appeared only with pEAQ-HT-GFP, an effect which was more pronounced at higher Agrobacterium concentrations (
Constructs containing mutations in the 5′ UTR of Rep/RepA with the goal of reducing expression of a recombinant protein in plants. pBYe-R1-GFP (R1 in
To evaluate the effects of the mutants on replicon DNA abundance, DNA was extracted from the plants expression and quantified using and performed agarose gel quantification.
Rep mutant vectors for expression of rituximab heavy and light chains were constructed in order to evaluate effects of mutations in the 5′ UTR of Rep/RepA on rituximab expression and cell death. pBYe-R2-MRtxG and pBYe-R2-MrtxK contain a mutation at −3 (relative to ATG start codon) of the Rep/RepA 5′ UTR (AACATG to CACATG; R2 Rep in
a. Vector Construction
A series of expression vectors containing promoters of varying strengths were created to express Rep and RepA. The Ubi3 promoter was obtained from pUbi3-GUS (Garbarino and Belknap, 1994) by BseRI (T4 blunt) PstI digestion, and ligated into pRep110 (Huang et al., 2009) digested SbfI (T4 blunt) and XhoI, to create pRep107. The Ubi3 promoter with ubiquitin fusion was excised from pUbi3-GUS by PstI-NcoI digestion and ligated into pRep110 digested SbfI-SacI along with C1/C2 excised from pBY036 digested NcoI-SacI to create pRep106. The soybean vspB promoter was obtained from pGUS220 (Mason et al., 1993) by HindIII-NcoI digestion and ligated with pRep110 digested HindIII-SacI and pBY034 digested NcoI-SacI to create pRep108. The Agrobacterium nopaline synthase (NOS) promoter was obtained from pGPTV-Kan (Becker et al., 1992) by HindIII-NcoI digestion and ligated into pBI101 (Jefferson et al., 1987) along with C1/C2 excised from pBY036 digested NcoI-SacI to create pRep111.
The intron-deleted form of BeYDV rep was previously described (Mor et al., 2003). For RepA vectors, the sequence following the RepA stop codon was deleted and an additional stop codon was inserted in the Rep reading frame to prevent further translation. To accomplish this, a primer RepA-Sac-R (5′-CGGAGCTCTATGTTAATTGCTTCCACAATGGGAC; SEQ ID NO. 1) designed to insert a stop codon and create a SacI site at the end of the RepA coding sequence was used to amplify RepA from pRep110 along with primer TEV (5′-GCATTCTACTTCTATTGCAGC; SEQ ID NO. 2). The product was digested ClaI-SacI and ligated into pRep110 digested likewise to yield pRepA110. XhoI-SacI or NcoI-SacI fragments containing either the deleted intron form of Rep excised from pBY037, or RepA excised from pRepA110, were ligated into expression vectors containing the promoters Ubi (pRep106), UbiF (pRep107), VspB (pRep108), or NOS (pRep111) to generate Rep and RepA expressing vectors.
To create BeYDV expression vectors that required Rep/RepA to be supplied in trans, Rep/RepA were deleted from the Norwalk virus capsid protein (NVCP)-expressing vector pBYR2e-sNV or the rituximab-expressing vector pBYR2e-MRtx (Diamos et al., 2016) by BamHI digestion and self-ligation of the backbone vector to yield pBY-2e-sNV and, pBY-2e-MRtx respectively. The empty replicon vector pBY-EMPTY was created by excising the PstI-SacI fragment from pKS-RT38, which contains the potato pinII terminator region derived from pRT38 (Thornburg et al., 1987), and ligating it into pBY-GFP (Huang et al., 2009) digested SbfI-SacI. To introduce a AACATG to CACATG mutation to the 5′ UTR of Rep/RepA, the primer LIRc-Nhe2-R (5′-taGCTAGCAGAAGGCATGTGGTTGTGACTCCGAGGGGTTG; SEQ ID NO. 3) containing the mutation was used to amplify the modified LIR from pBY027 with primer M13F. The PCR product was digested NheI-AgeI and ligated into pBYR2e-GFP digested BspDI-AgeI along with the rep-containing NheI-BspDI fragment from pBYR2e-GFP to create pBY-R2-GFP. Vectors containing NbPsaK, PEMV and BYDV 3′ and 5′ UTRs were previously described (Diamos et al., 2016; Diamos and Mason, 2018).
b. Agroinfiltration of N. benthamiana Leaves
Binary vectors were separately introduced into Agrobacterium tumefaciens GV3101 or EHA105 by electroporation. The resulting strains were verified by restriction digestion or PCR, grown overnight at 30° C., and used to infiltrate leaves of 5- to 6-week-old N. benthamiana maintained at 23-25° C. Briefly, the bacteria were pelleted by centrifugation for 5 min at 5,000 g and then resuspended in infiltration buffer (10 mM 2-(N-morpholino)ethanesulfonic acid (IVIES), pH 5.5 and 10 mM MgSO4) to OD600=0.2, unless otherwise described. When mixing two constructs, each Agrobacterium concentration was instead set to OD600=0.4, and then mixed 1:1. Similarly, for three constructs, each was set to OD600=0.6, and mixed 1:1:1. The resulting bacterial suspensions were injected by using a syringe without needle into fully expanded leaves (9-12 cm long) through a small puncture (Huang et al. 2004). Plant tissue was harvested after 5 DPI, or as stated for each experiment. Leaves producing GFP were photographed under UV illumination generated by a B-100AP lamp (UVP, Upland, Calif., USA).
c. Protein Extraction
Total protein extract was obtained by homogenizing agroinfiltrated leaf samples with 1:5 (w:v) ice cold extraction buffer (25 mM sodium phosphate, pH 7.4, 100 mM NaCl, 1 mM EDTA, 0.1% Triton X-100, 10 mg/mL sodium ascorbate, 0.3 mg/mL phenylmethylsulfonyl fluoride) using a Bullet Blender machine (Next Advance, Averill Park, N.Y., USA) following the manufacturer's instruction. To enhance solubility, homogenized tissue was rotated at room temperature or 4° C. for 30 minutes. The crude plant extract was clarified by centrifugation at 13,000 g for 10 min at 4° C. Necrotic leaf tissue has reduced water weight, which can lead to inaccurate measurements based on leaf mass. Therefore, extracts were normalized based on total protein content by Bradford protein assay kit (Bio-Rad, Hercules, Calif., USA) with bovine serum albumin as standard.
d. SDS-PAGE and Western Blot
Clarified plant protein extract was mixed with sample buffer (50 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 0.02% bromophenol blue) and separated on 4-15% polyacrylamide gels (Bio-Rad, Hercules, Calif., USA). For reducing conditions, 0.5 M dithiothreitol was added, and the samples were boiled for 10 min prior to loading. Polyacrylamide gels were either transferred to a PVDF membrane or stained with Coomassie stain (Bio-Rad, Hercules, Calif., USA) following the manufacturer's instructions. For Rep/RepA detection, the protein transferred membranes were blocked with 5% dry milk in PBST (PBS with 0.05% tween-20) for 1 h at 37° C. and probed in succession with rabbit anti-Rep (antibodies raised against an N-terminal 154 amino acid fragment of Rep/RepA) diluted 1:2000 and goat anti-rabbit IgG-horseradish peroxidase conjugated (Sigma-Aldrich, St. Louis, Mo., USA) diluted 1:10,000 in 1% PBSTM. Bound antibody was detected with ECL reagent (Amersham, Little Chalfont, United Kingdom). For GFP detection, the 26 kDa fluorescent GFP band was quantified by gel densitometry using ImageJ software.
e. Protein Quantification by ELISA
GI and GII norovirus capsid concentration was analyzed by sandwich ELISA. A rabbit polyclonal anti-GI or anti-GII antibody was bound to 96-well high-binding polystyrene plates (Corning, Corning, N.Y., USA), and the plates were blocked with 5% nonfat dry milk in PBST. After washing the wells with PBST (PBS with 0.05% Tween 20), the plant extracts were added and incubated. The bound norovirus capsids were detected by incubation with guinea pig polyclonal anti-GI or anti-GII antibody followed by goat anti-guinea pig IgG-horseradish peroxidase conjugate. The plate was developed with TMB substrate (Thermo Fisher Scientific, Waltham, Mass., USA) and the absorbance was read at 450 nm. Plant-produced GI or GII capsids were used as the reference standard (Kentucky Bio Processing, Kentucky, USA).
For rituximab quantification, plant protein extracts were analyzed by ELISA designed to detect the assembled form of mAb (with both light and heavy chains) as described previously (Giritch et al. 2006). Briefly, plates were coated with a goat anti-human IgG specific to gamma heavy chain (Southern Biotech, Birmingham, Ala., USA). After incubation with plant protein extract, the plate was blocked with 5% non-fat dry milk in PBST, then incubated with a HRP-conjugated anti-human-kappa chain.
f. Plant DNA Extraction and Replicon Quantification
Total DNA was extracted from 0.1 g plant leaf samples using the DNeasy Plant Mini Kit (Qiagen) according to the manufacturer's instructions. DNA (˜1 μg) was separated on 1% agarose gels stained with ethidium bromide. The replicon DNA band intensity was quantified using ImageJ software, using the high molecular weight plant chromosomal DNA band as an internal loading control. Columns represent means±standard deviation from 3 or more independently infiltrated samples.
g. RT-PCR
Total RNA was extracted from 0.1 g leaf samples using the RNeasy Plant Mini Kit (Qiagen) according to the manufacturer's instructions. Residual DNA was removed using the DNA-Free system (Ambion). First-strand cDNA was synthesized from 1 μg of total RNA primer using the Superscript III First Strand Synthesis System (Invitrogen) according to the manufacturer's instructions using oligo dT22 primer. RT-PCR was performed using primers RepF (5′-ACCCCAAGTGCTCATCTC) and RepR1 (5′-GCGACACGTACTGCTCA) to detect Rep and RepA transcripts.
This application claims the benefit of U.S. provisional patent application 62/841,098, filed Apr. 30, 2019 titled “Geminiviral Vectors That Reduce Cell Death and Enhance Expression of Biopharmaceutical Proteins,” the entirety of the disclosure of which is hereby incorporated by this reference.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US20/30784 | 4/30/2020 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
62841098 | Apr 2019 | US |